Pharmacogenetics of breast cancer: toward the individualization of therapy.
作者信息
Chang Jenny C, Hilsenbeck Susan G, Fuqua Suzanne A W
机构信息
Breast Center, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
出版信息
Cancer Invest. 2009 Aug;27(7):699-703. doi: 10.1080/07357900903152473.
PMID:19637041
Abstract
摘要
相似文献
1
Pharmacogenetics of breast cancer: toward the individualization of therapy.乳腺癌的药物遗传学：迈向个体化治疗
Cancer Invest. 2009 Aug;27(7):699-703. doi: 10.1080/07357900903152473.
2
Integrated gene expression profile predicts prognosis of breast cancer patients.综合基因表达谱可预测乳腺癌患者的预后。
Breast Cancer Res Treat. 2009 Jan;113(2):231-7. doi: 10.1007/s10549-008-9925-4. Epub 2008 Feb 16.
3
High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases.BRCA1相关肿瘤对顺铂单药治疗的高敏感性：两例报告。
Cancer Genet Cytogenet. 2010 Feb;197(1):91-4. doi: 10.1016/j.cancergencyto.2009.10.003.
4
Molecular assays to predict prognosis of breast cancer.预测乳腺癌预后的分子检测
Clin Adv Hematol Oncol. 2007 Sep;5(9):681-2.
5
Personalized systemic treatment for breast cancer patients: is it a reality?乳腺癌患者的个性化系统治疗：这是现实吗？
Breast Cancer. 2008;15(2):141-4. doi: 10.1007/s12282-008-0029-0.
6
Antiangiogenic therapy in patients with HER2-positive metastatic breast cancer: a case series.HER2阳性转移性乳腺癌患者的抗血管生成治疗：病例系列
Clin Breast Cancer. 2014 Jun;14(3):e89-94. doi: 10.1016/j.clbc.2013.11.005. Epub 2013 Nov 21.
7
Management of young breast cancer patients with de novo genetic mutations.初发性基因突变的年轻乳腺癌患者的管理
Oncology (Williston Park). 2014 Oct;28(10):895-6.
8
Genetic profiling can predict chemotherapy side effects and treatment response.基因图谱分析能够预测化疗副作用及治疗反应。
Expert Rev Mol Diagn. 2003 Jul;3(4):406-7.
9
Adjuvant chemotherapy for breast cancer in pregnancy: can recommendations be made with confidence.
Semin Oncol. 1997 Apr;24(2):xxv-xxxvi; discussion xxxvi, xxxix.
10
Pharmacogenetics in the treatment of breast cancer.
Pharmacogenomics J. 2004;4(3):143-53. doi: 10.1038/sj.tpj.6500242.
引用本文的文献
1
Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.类固醇受体共激活因子-3（SRC-3/AIB1）作为三阴性乳腺癌的新型治疗靶点及其磷酸化蟾毒灵前药对其的抑制作用
PLoS One. 2015 Oct 2;10(10):e0140011. doi: 10.1371/journal.pone.0140011. eCollection 2015.
Zotero 插件